At-Home Aesthetics Startup Lands Growth Capital
Persimmon.Life, a provider of at-home aesthetics and wellness services, has secured a multi-million-dollar investment from Decathlon Capital Partners. The deal is structured as flexible, dilution-free growth capital, a structure often used by companies that want to fund expansion without giving up equity.
The deal's structure is a form of revenue-based financing (RBF), a popular non-dilutive funding model. Unlike venture capital, RBF doesn't involve selling equity; instead, Persimmon.Life will repay the capital by sharing a percentage of its future monthly revenue until a predetermined amount is returned, typically a small multiple of the original investment. Decathlon Capital Partners is one of the largest investors specializing in this type of growth capital. The firm typically backs companies with annual revenues between $4 million and $100 million and a growth rate of over 10%, providing an alternative to traditional VC funding for businesses that want to scale without giving up ownership or control. Persimmon.Life, founded in 2021, operates as a tech-enabled service, connecting a network of over 500 registered nurses with clients seeking at-home treatments. Its value proposition hinges on convenience and cost, claiming to offer premium services like Botox and IV wellness therapies at prices 15-25% lower than traditional medspas. The company's expansion strategy is not limited to homes. Persimmon recently inked a partnership with Massage Envy to offer its injectable treatments, such as Xeomin, at select franchise locations in states like Arizona and California, tapping into an existing customer base for wellness services. This investment follows a prior funding round in May 2025 from Auréa Group, a private equity firm focused on beauty and wellness. That deal was intended to fuel geographic expansion and create distribution opportunities, signaling a clear strategic roadmap for scaling the company's unique service delivery model. The deal taps into a booming market for at-home beauty and wellness, driven by consumer demand for convenience and non-invasive procedures. The global market for home-use beauty devices alone is projected to exceed $21 billion by 2030, while the broader aesthetic medicine market was valued at over $82 billion in 2023.
